SEC CIK 1720007

Dexcel Pharma Technologies Ltd.

Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ABUSview stock →16,013,5402017-09-06
PLXview stock →3,637,3142021-06-03

Position History — ABUS

Reported shares owned immediately after each Form 4 transaction, over time.

Not enough filing history yet to chart a trend for ABUS.

Recent Filings — ABUS

DateActivitySharesPriceOwned After
2018-01-12Open-market buy (derivative)664,000$100.001,164,000
2017-10-16Open-market buy (derivative)500,000$100.00500,000
2017-09-06———16,013,540

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.